DUBLIN–(BUSINESS WIRE)–The “Respiratory Inhalers Market – Global Outlook and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Respiratory Inhalers Market Report
The respiratory inhalers market by revenue is expected to grow at a CAGR of over 9% during the period 2019-2025.
The global respiratory inhalers market is one of the steadily growing segments in the medical devices market. The steady growth can be attributed to the growing prevalence of asthma, COPD, and cystic fibrosis and the outbreak of the COVID-19 pandemic. The prevalence of COPD and other respiratory disorders demanding inhalers has increased at a significant rate over the last few years across the globe. According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.
The increasing incidence of respiratory diseases and the growing demand for treatment options for respiratory disorders are fueling the market growth of therapeutic respiratory care devices such as inhalers. Further, the presence of established infrastructure in several countries of North America, Europe, and APAC, coupled with the availability of well-developed technologies that allow early implementation of advanced inhalation technologies, increases the demand for inhalers. Favorable government initiatives in emerging economies toward improvising standard healthcare infrastructure and increased focus on healthcare expenditure are also aiding to focus on offering high-quality healthcare services.
The following factors are likely to contribute to the growth of the respiratory inhalers market during the forecast period:
- Increase in Usage of Smart Inhaler
- Introduction of Soft Mist Inhalers
- Increase in Target Population
- Surge in Inhalers Usage due to COVID-19
INSIGHTS BY VENDORS
The global respiratory inhalers market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of products. GSK, Novartis, BOEHRINGER INGELHEIM, Cipla, and AstraZeneca are the key players dominating the global inhalers market. Although large vendors dominate the market, they are witnessing heavy competition from regional and local companies from India, China, Italy, and Germany. Many regional vendors are also offering cost-effective products in Europe, APAC, and the Middle East & Africa regions.
Prominent Vendors
- GlaxoSmithKline
- Novartis
- Boehringer Ingelheim
- Cipla
- AstraZeneca
Other Prominent Vendors
- Propeller Health
- Beximco Pharmaceuticals (Beximco Pharma)
- H&T Presspart
- Cohero Health
- CHIESI Farmaceutici
- Mundipharma
- 3M
- HELTMAN Medikal
- Adherium
- Luckys Pharma
- Amiko Digital Health
- Teva Pharmaceutical Industries
- Findair Sp.z.o.o
- Vectura Group
For more information about this report visit https://www.researchandmarkets.com/r/kkl6xh
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900